IMUC in the News

Latest

Proactive Investors article: ImmunoCellular Therapeutics armed with platform to “effectively eradicate” cancer.
Link: http://www.proactiveinvestors.com/companies/news/36913/immunocellular-therapeutics-armed-with-platform-to-effectively-eradicate-cancer-36913.html

ImmunoCellular selected by the Society for Immunotherapy of Cancer (SITC) to present results of Phase I study at the 27th Annual Meeting:
Link: http://www.sitcancer.org/UserFiles/SITCAM12NewsworthyAbstractsRelease.pdf

---

Videos

November 14, 2012 - ImmunoCellular Therapeutics fully funded to end of Phase II trials

---

July 19, 2012 - IMUC rings the opening bell at the New York Stock Exchange

---

CBS - June 7th 2011 - Vaccine for brain tumor

---

ABC 7 - Feb 14th 2011 - Vaccine may give brain cancer patients time

---